Dr. Padda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8835 Germantown Ave
Philadelphia, PA 19118Phone+1 215-728-2570Fax+1 215-728-3639
Education & Training
- Stanford Health CareFellowship, 2011 - 2014
- Northeast Ohio Medical UniversityClass of 2007
Certifications & Licensure
- CA State Medical License 2009 - 2026
- PA State Medical License 2023 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A Phase 2 Single-Arm Trial of High-Dose Precision Targeted Radiation Therapy Added to Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer.Michael F Gensheimer, Nikhil V Kotha, Lucas K Vitzthum, Alexander L Chin, Scott Jackson
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01 - Afatinib and Necitumumab in-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors.Nathaniel J Myall, Jennifer G Whisenant, Joel W Neal, Wade T Iams, Karen L Reckamp
JTO Clinical and Research Reports. 2025-02-01 - Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced-Mutant NSCLC.Jacqueline V Aredo, Heather A Wakelee, Kavitha J Ramchandran, Joel W Neal, Maximilian Diehn
JTO Clinical and Research Reports. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: